| Title |
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
|
|---|---|
| Published in |
JAMA Oncology, January 2023
|
| DOI | 10.1001/jamaoncol.2022.5370 |
| Pubmed ID | |
| Authors |
Linda M. Liau, Keyoumars Ashkan, Steven Brem, Jian L. Campian, John E. Trusheim, Fabio M. Iwamoto, David D. Tran, George Ansstas, Charles S. Cobbs, Jason A. Heth, Michael E. Salacz, Stacy D’Andre, Robert D. Aiken, Yaron A. Moshel, Joo Y. Nam, Clement P. Pillainayagam, Stephanie A. Wagner, Kevin A. Walter, Rekha Chaudhary, Samuel A. Goldlust, Ian Y. Lee, Daniela A. Bota, Heinrich Elinzano, Jai Grewal, Kevin Lillehei, Tom Mikkelsen, Tobias Walbert, Steven Abram, Andrew J. Brenner, Matthew G. Ewend, Simon Khagi, Darren S. Lovick, Jana Portnow, Lyndon Kim, William G. Loudon, Nina L. Martinez, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Pierre Giglio, Oleg Gligich, Dietmar Krex, Scott M. Lindhorst, Jose Lutzky, Hans-Jörg Meisel, Minou Nadji-Ohl, Lhagva Sanchin, Andrew Sloan, Lynne P. Taylor, Julian K. Wu, Erin M. Dunbar, Arnold B. Etame, Santosh Kesari, David Mathieu, David E. Piccioni, David S. Baskin, Michel Lacroix, Sven-Axel May, Pamela Z. New, Timothy J. Pluard, Steven A. Toms, Victor Tse, Scott Peak, John L. Villano, James D. Battiste, Paul J. Mulholland, Michael L. Pearlman, Kevin Petrecca, Michael Schulder, Robert M. Prins, Alton L. Boynton, Marnix L. Bosch |
Twitter Demographics
The data shown below were collected from the profiles of 597 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 170 | 28% |
| United Kingdom | 11 | 2% |
| India | 9 | 2% |
| Canada | 8 | 1% |
| Denmark | 6 | 1% |
| Australia | 5 | <1% |
| Spain | 5 | <1% |
| Germany | 4 | <1% |
| Italy | 3 | <1% |
| Other | 40 | 7% |
| Unknown | 336 | 56% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 498 | 83% |
| Scientists | 52 | 9% |
| Practitioners (doctors, other healthcare professionals) | 37 | 6% |
| Science communicators (journalists, bloggers, editors) | 7 | 1% |
| Unknown | 3 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 81 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 17% |
| Unspecified | 7 | 9% |
| Student > Bachelor | 6 | 7% |
| Student > Ph. D. Student | 6 | 7% |
| Other | 4 | 5% |
| Other | 12 | 15% |
| Unknown | 32 | 40% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 11 | 14% |
| Biochemistry, Genetics and Molecular Biology | 8 | 10% |
| Unspecified | 8 | 10% |
| Immunology and Microbiology | 6 | 7% |
| Neuroscience | 4 | 5% |
| Other | 14 | 17% |
| Unknown | 30 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1176. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 September 2023.
All research outputs
#11,437
of 24,489,051 outputs
Outputs from JAMA Oncology
#12
of 3,178 outputs
Outputs of similar age
#333
of 454,794 outputs
Outputs of similar age from JAMA Oncology
#1
of 85 outputs
Altmetric has tracked 24,489,051 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,178 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 85.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 454,794 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.